Login / Signup

Intestinal Predictors of Whole Blood Serotonin Levels in Children With or Without Autism.

Miranda Zuniga-KennedyMicah DavorenLauren C ShuffreyRuth Ann LunaTor SavidgeVinay PrasadGeorge M AndersonJeremy Veenstra-VanderWeeleKent C Williams
Published in: Journal of autism and developmental disorders (2022)
Hyperserotonemia, or elevated levels of whole blood serotonin (WB5-HT), was the first biomarker linked to autism spectrum disorder (ASD). Despite numerous studies investigating the etiology of hyperserotonemia, results have been inconsistent. Recent findings suggest a relationship between the immune system and hyperserotonemia. The current study investigated whether intestinal 5-HT levels, 5-HT gene expression, or intestinal cell types predict WB5-HT. Participants included thirty-one males aged 3-18 who were classified into one of three groups: ASD and functional GI issues, typically developing with GI issues, and typically developing without GI issues. Samples from a lower endoscopy were analyzed to examine the pathways in predicting WB-5HT. Results demonstrated an association between T-Lymphocytes and WB5-HT.
Keyphrases
  • autism spectrum disorder
  • gene expression
  • intellectual disability
  • attention deficit hyperactivity disorder
  • young adults
  • single cell
  • stem cells
  • cell therapy
  • case control